NorthSea Therapeutics
PrivateLast Round
Series C
Dec 17, 2021
Total Funding Raised
$149.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NorthSea Therapeutics is a biotechnology company that develops novel therapeutic drugs for metabolic, inflammatory, and liver diseases using its proprietary Structurally Engineered Fatty Acid (SEFA) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NorthSea Therapeutics Comparables
Compare NorthSea Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sagimet Biosciences | 82% | |
| Inventiva S.A. | 80% | |
| Galmed Pharmaceuticals | 79% |
NorthSea Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Dec 17, 2021 | ||||
| Series B | Jan 8, 2020 | ||||
| Series A | Dec 12, 2017 |
Key People
Founding team and executive leadership
NorthSea Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Series C |
| Forbion | Series B, Series C, Series A |
| Ysios Capital | Series C |
| Flerie Invest | Series C, Series A, Series B |
| Novo Holdings | Series B, Series C, Series A |
| Novoseeds | Series B, Series C, Series A |
| venBio | Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors increased 56% MoM.
- Apr 20, 2026
Monthly visitors grew 503% MoM, reaching 1.6K.
NorthSea Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NorthSea Therapeutics's valuation, stock price, and market status.
Is NorthSea Therapeutics a public or private company?
NorthSea Therapeutics is a private company.
What is the current stock price of NorthSea Therapeutics?
NorthSea Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is NorthSea Therapeutics worth (valuation)?
Valuation information for NorthSea Therapeutics is not publicly available.
Can I buy NorthSea Therapeutics stock?
NorthSea Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NorthSea Therapeutics's last funding round?
NorthSea Therapeutics's most recent funding round was Series C on December 17, 2021.
Who are the main investors in NorthSea Therapeutics?
Key investors in NorthSea Therapeutics include Ysios Capital, Flerie Invest, venBio, BioGeneration Ventures.
Will NorthSea Therapeutics IPO soon?
No public IPO plans have been announced for NorthSea Therapeutics.
How can I track NorthSea Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NorthSea Therapeutics's secondary market activity and sign up for updates.